NASDAQ:PTGX
Protagonist Therapeutics, Inc.
- Stock
Last Close
31.94
17/05 20:00
Market Cap
1.80B
Beta: 1.95
Volume Today
437.12K
Avg: 1.73M
PE Ratio
−11.44
PFCF: −12.63
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 636.50K - | -3.19M 601.89% | -8.20M 156.66% | -3.30M 59.71% | 3.47M 204.95% | 4.39M 26.49% | 6.24M 42.28% | 4.20M 32.61% | -47K 101.12% | ||
average payables | 798K - | 1.21M 51.00% | 1.21M 0.41% | 3.48M 187.93% | 4.25M 22.00% | 2.93M 31.01% | 2.34M 20.29% | 2.62M 12.09% | 2.21M 15.80% | ||
average receivables | 619K - | 1.48M 138.77% | 2.70M 82.81% | 4.59M 69.86% | 6.39M 39.13% | 5.13M 19.62% | 3.93M 23.35% | 2.21M 43.95% | 26K 98.82% | ||
book value per share | 1.35 - | 1.63 20.63% | -9.93 709.26% | -5.74 42.23% | -6.28 9.44% | -8.41 33.83% | -8.25 1.84% | -8.84 7.10% | -10.94 23.85% | 0.01 100.05% | |
capex per share | -0.05 - | -0.07 33.44% | -0.06 14.03% | -0.04 35.43% | -0.02 42.26% | -0.04 71.85% | -0.01 63.33% | -0.02 73.57% | -0.02 31.80% | -0.00 99.93% | |
capex to depreciation | -1.16 - | -1.62 39.39% | -1.20 25.99% | -1.64 37.20% | -0.92 43.78% | -0.39 57.97% | -0.18 52.60% | -0.40 115.98% | -0.24 40.52% | -0.18 22.08% | |
capex to operating cash flow | 0.04 - | 0.03 28.17% | 0.01 54.41% | -0.17 1,460.24% | 0.01 105.66% | 0.02 139.31% | 0.01 72.09% | 0.01 57.08% | 0.01 27.97% | 0.01 17.94% | |
capex to revenue | -0.03 - | -0.02 52.66% | -4.19 26,537.16% | -0.02 99.61% | -0.04 144.62% | -0.03 25.68% | -0.01 66.06% | ||||
cash per share | 1.58 - | 2.03 27.87% | 11.94 489.08% | 8.14 31.81% | 5.76 29.20% | 5.14 10.84% | 8.89 73.07% | 7.06 20.63% | 4.84 31.42% | 0.01 99.88% | |
days of inventory on hand | |||||||||||
days payables outstanding | |||||||||||
days sales outstanding | 57.54 - | 71.01 23.39% | 10.67K 14,931.95% | 44.75 99.58% | 58.14 29.93% | 0.71 98.77% | |||||
debt to assets | 0.01 - | 0.11 1,343.45% | 0.02 83.27% | 0.02 8.26% | 0.01 12.48% | 0.00 78.38% | |||||
debt to equity | -0.01 - | -0.08 934.74% | -0.02 73.13% | -0.01 31.85% | -0.01 52.40% | 0.00 149.76% | |||||
dividend yield | |||||||||||
earnings yield | -0.16 - | -0.22 34.19% | -0.26 20.50% | -0.10 61.38% | -0.26 157.54% | -0.42 63.50% | -0.10 77.44% | -0.08 18.86% | -0.23 197.99% | -0.00 99.97% | |
enterprise value | 59.53M - | 64.80M 8.85% | 121.89M 88.11% | 262.02M 114.96% | 68.28M 73.94% | 166.56M 143.93% | 582.03M 249.45% | 1.47B 151.95% | 412.96M 71.84% | 1.30T 315,038.06% | |
enterprise value over ebitda | -8.16 - | -4.48 45.12% | -4.36 2.64% | -6.91 58.52% | -1.62 76.64% | -2.14 32.68% | -9.14 326.55% | -11.68 27.75% | -3.14 73.09% | -13.90K 441,968.86% | |
ev to operating cash flow | -7.69 - | -4.50 41.41% | -4.07 9.72% | 67.67 1,763.95% | -1.37 102.02% | -4.01 193.39% | -8.03 100.20% | -13.60 69.31% | -3.82 71.91% | -18.53K 485,093.99% | |
ev to sales | 13.06 - | 2.21 83.09% | 721.03 32,556.39% | 20.33 97.18% | 53.60 163.66% | 15.54 71.02% | 21.69K 139,511.41% | ||||
free cash flow per share | -1.37 - | -2.51 83.83% | -4.67 85.82% | 0.18 103.88% | -2.26 1,344.60% | -1.64 27.23% | -2.12 29.24% | -2.35 10.91% | -2.22 5.57% | -0.00 99.94% | |
free cash flow yield | -0.12 - | -0.21 83.83% | -0.21 1.13% | 0.01 104.10% | -0.34 3,946.61% | -0.23 30.53% | -0.11 54.80% | -0.07 34.62% | -0.20 196.00% | -0.00 99.97% | |
graham net net | 1.25 - | 1.33 6.72% | 10.62 696.63% | 5.59 47.35% | 4.81 14.02% | 2.53 47.34% | 7.72 205.10% | 6.19 19.82% | -11.16 280.29% | 0.01 100.05% | |
graham number | 7.56 - | 9.62 27.23% | 35.75 271.46% | 16.42 54.06% | 15.68 4.50% | 23.74 51.40% | 18.90 20.42% | 22.94 21.42% | 24.89 8.50% | 0.01 99.95% | |
income quality | 0.70 - | 0.97 38.44% | 0.81 16.73% | -0.10 113.00% | 1.28 1,324.77% | 0.54 58.07% | 1.10 103.67% | 0.86 21.59% | 0.85 1.20% | 0.89 4.80% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -476.46 - | -107.89 77.36% | 38.99 - | ||||||||
interest debt per share | 0.05 - | 0.66 1,298.52% | 0.19 71.27% | 0.13 33.66% | 0.01 95.37% | 0.00 99.66% | |||||
inventory turnover | |||||||||||
invested capital | -0.01 - | -0.08 934.74% | -0.02 73.13% | -0.01 31.85% | -0.01 52.40% | 0.00 149.76% | |||||
market cap | 68.85M - | 68.85M 0% | 142.97M 107.65% | 368.05M 157.42% | 150.51M 59.10% | 182.55M 21.29% | 693.43M 279.85% | 1.58B 128.46% | 535.05M 66.23% | 1.30T 243,164.48% | |
net current asset value | 7.54M - | 8.96M 18.79% | 76.81M 757.53% | 107.84M 40.41% | 110.55M 2.50% | 70.36M 36.35% | 270.74M 284.81% | 293.06M 8.24% | -547.33M 286.76% | 334.30M 161.08% | |
net debt to ebitda | 1.28 - | 0.28 78.07% | 0.75 169.10% | 2.80 270.85% | 1.95 30.46% | 0.21 89.42% | 1.75 750.14% | 0.94 46.38% | 0.93 0.96% | 1.98 113.24% | |
net income per share | -1.88 - | -2.52 34.19% | -5.72 126.47% | -2.09 63.47% | -1.74 16.67% | -2.98 71.27% | -1.92 35.48% | -2.65 37.65% | -2.52 4.94% | -0.00 99.94% | |
operating cash flow per share | -1.32 - | -2.44 85.78% | -4.61 88.59% | 0.22 104.75% | -2.23 1,120.59% | -1.60 28.19% | -2.11 31.40% | -2.33 10.50% | -2.20 5.31% | -0.00 99.94% | |
payables turnover | |||||||||||
receivables turnover | 6.34 - | 5.14 18.96% | 0.03 99.33% | 8.16 23,750.49% | 6.28 23.03% | 511.17 8,043.04% | |||||
research and ddevelopement to revenue | 2.30 - | 1.92 16.42% | 281.40 14,526.35% | 2.60 99.08% | 4.61 76.98% | 4.75 3.09% | 2.00 57.82% | ||||
return on tangible assets | -1.07 - | -1.00 6.64% | -0.40 60.48% | -0.23 42.94% | -0.28 23.64% | -0.50 78.53% | -0.20 59.08% | -0.35 72.99% | -0.50 41.14% | -0.22 55.69% | |
revenue per share | 1.13 - | 1.38 21.95% | 0.01 99.35% | 0.83 9,229.64% | 0.59 29.04% | 0.54 8.22% | 0.00 99.80% | ||||
roe | -1.39 - | -1.55 11.25% | 0.58 137.17% | 0.36 36.77% | 0.28 23.86% | 0.35 27.98% | 0.23 34.27% | 0.30 28.52% | 0.23 23.25% | -0.23 202.00% | |
roic | -1.36 - | -1.55 14.10% | 0.56 136.32% | 0.37 34.36% | 0.30 19.51% | 0.41 38.87% | 0.24 41.33% | 0.31 27.70% | 0.24 22.23% | -0.28 214.94% | |
sales general and administrative to revenue | 0.59 - | 0.44 24.56% | 68.18 15,293.07% | 0.65 99.05% | 0.99 52.70% | 1.19 20.11% | 0.56 53.25% | ||||
shareholders equity per share | 1.35 - | 1.63 20.63% | -9.93 709.26% | -5.74 42.23% | -6.28 9.44% | -8.41 33.83% | -8.25 1.84% | -8.84 7.10% | -10.94 23.85% | 0.01 100.05% | |
stock based compensation to revenue | 0.21 - | 0.22 5.84% | 36.16 16,062.07% | 0.28 99.24% | 0.60 117.20% | 0.91 51.93% | 0.49 46.38% | ||||
tangible asset value | 7.96M - | 9.60M 20.63% | 87.56M 812.41% | 120.63M 37.78% | 112.52M 6.73% | 79.96M 28.93% | 279.61M 249.66% | 300.02M 7.30% | -536.75M 278.91% | 336.68M 162.72% | |
tangible book value per share | 1.35 - | 1.63 20.63% | 13.47 725.84% | 6.82 49.37% | 5.03 26.21% | 3.09 38.62% | 8.13 163.23% | 6.48 20.32% | -10.94 268.99% | 0.01 100.05% | |
working capital | 8.56M - | 11.08M 29.39% | 76.81M 593.22% | 108.39M 41.12% | 111.34M 2.72% | 109.91M 1.29% | 275.37M 150.55% | 296.72M 7.76% | 206.18M 30.51% | 334.30M 62.14% |
All numbers in USD (except ratios and percentages)